Nambara S et al., 2017-12: Gastric cancer study showing that ivermectin suppresses tumour growth in YAP1-high MKN1 xenografts but not YAP1-low MKN7 cells, lowering YAP1 mRNA, nuclear YAP1 and CTGF, so that sensitivity depends on YAP1 expression.
In MKN1 xenografts, ivermectin suppressed tumor growth, and the sensitivity of MKN1 cells to ivermectin was decreased by YAP1 knockdown.
n/a (HTML full text)
Nambara S et al., 2017-12: Gastric cancer study showing that ivermectin suppresses tumour growth in YAP1-high MKN1 xenografts but not YAP1-low MKN7 cells, lowering YAP1 mRNA, nuclear YAP1 and CTGF, so that sensitivity depends on YAP1 expression. Study type: gastric cancer cell lines + mouse xenograft + clinical dataset analysis. N: not stated in the abstract (three independent GC datasets used for survival analysis). Country: Japan (Kyushu University Beppu Hospital). Dose: not stated in the abstract. Declared COI: 'The authors declare no conflicts of interest.' Comparator: YAP1 knockdown vs control, MKN1 vs MKN7. This is the YAP1 target paper named indirectly in C8. Also filed as IVA-20 (claims C5, C8). Study type: animal.
